01 1Viyash Life Sciences Private Limited
01 1Sangjin Trading Co., Ltd.
01 1Labetalol hydrochloride
01 1U.S.A
Registrant Name : Sangjin Trading Co., Ltd.
Registration Date : 2025-12-17
Registration Number : 20251217-210-J-2078
Manufacturer Name : Viyash Life Sciences Private...
Manufacturer Address : Plot No.28,Sy.No.1,3,9&26, Jawaharlal Nehru Pharma City, Thanam Village, Parawada Man...
71
PharmaCompass offers a list of Labetalol Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Labetalol Hydrochloride manufacturer or Labetalol Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Labetalol Hydrochloride manufacturer or Labetalol Hydrochloride supplier.
A Labetalol manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Labetalol, including repackagers and relabelers. The FDA regulates Labetalol manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Labetalol API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Labetalol manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Labetalol supplier is an individual or a company that provides Labetalol active pharmaceutical ingredient (API) or Labetalol finished formulations upon request. The Labetalol suppliers may include Labetalol API manufacturers, exporters, distributors and traders.
click here to find a list of Labetalol suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Labetalol Drug Master File in Korea (Labetalol KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Labetalol. The MFDS reviews the Labetalol KDMF as part of the drug registration process and uses the information provided in the Labetalol KDMF to evaluate the safety and efficacy of the drug.
After submitting a Labetalol KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Labetalol API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Labetalol suppliers with KDMF on PharmaCompass.
